Private Weight Loss Injections in Manchester and Cheshire

Eligibility depends on your BMI, ethnicity, overall health, existing medical conditions, and the medications you’re already taking. In general, weight loss injections may be considered if you have:

• A BMI over 30
• A BMI of 27 kg/m² or more if you are of Asian descent
• A BMI of 27 kg/m² or more, of any ethnicity, where there is at least one weight-related co-morbidity such as diabetes or pre-diabetes, raised cholesterol, hypertension, cardiovascular disease, or sleep apnoea

At your initial consultation, Dr Summerhill will take a full history and let you know whether weight loss injections are clinically appropriate for you, or whether a different approach would suit you better.

Both are once-weekly injections that work on gut hormone pathways to reduce appetite, slow gastric emptying, and improve how the body handles blood sugar. Both carry UK approval for weight management.

• Mounjaro (tirzepatide) stimulates two gut hormone receptors (GIP and GLP-1).
• Wegovy (semaglutide) stimulates the GLP-1 receptor alone.

The right choice depends on your medical history, your tolerance to side effects, your goals, and current supply. Ozempic (semaglutide) uses the same active ingredient as Wegovy but is licensed in the UK for type 2 diabetes only, not for weight loss, so we don’t prescribe it as a weight loss therapy.

GLP-1 medications are effective, but they’re not a one-size-fits-all treatment. Pre-treatment bloods help us:

• Screen for undiagnosed diabetes, thyroid issues, or kidney or liver problems
• Check that your pancreatic and lipid markers are within a safe range to start
• Give us a baseline so we can spot any changes during treatment

It’s the same principle as our approach to TRT and hormone therapy: medication works best when we know what we’re treating, and what we need to keep an eye on.

Often, yes. We’ll need recent results covering thyroid function tests (TFTs), HbA1c, and lipid profile. If your existing tests don’t cover the full panel, we’ll let you know what’s missing before your treatment start consultation, so you can either top up or book a new test with us.

Most patients tolerate GLP-1 medications well, especially when the dose is built up gradually. The most common side effects in the early weeks include:

• Nausea, particularly after dose increases
• Mild gastrointestinal symptoms such as reflux, constipation, or loose stools
• Reduced appetite and earlier fullness (which is, of course, part of how the medication works)
• Fatigue or headaches in some patients

More serious but rarer risks include pancreatitis, gallbladder problems, and, with semaglutide and tirzepatide, specific warnings around certain thyroid conditions. We’ll go through your personal risk profile at your initial consultation, and our monitoring schedule is designed to catch any concerns early.

Weight loss injections are not appropriate during pregnancy or breastfeeding, and we’ll discuss other situations where treatment may not be suitable.

Most patients notice changes in appetite within the first one to two weeks. Visible weight loss tends to follow over the first one to three months, and continues as the dose is built up. Average weight loss with Mounjaro and Wegovy in clinical trials sits in the 15 to 20 per cent range over 12 to 18 months, although individual results vary depending on dose, lifestyle, and how the medication is combined with sustainable changes to eating and activity.

We’ll review your progress at every follow-up and adjust the plan as needed.

The evidence is clear that weight regain is common after stopping GLP-1 medications, especially if the underlying habits haven’t changed. That’s why we treat the injection as one part of a wider plan and not the whole plan. At every consultation, we work with you on the nutrition, movement, sleep, and stress factors that support long-term results, and we’ll talk through how to taper or stop treatment safely when the time is right.

We completely understand. Some patients find self-injection straightforward, others find it harder for reasons including needle anxiety, dexterity, or simply a preference for clinical oversight. We can administer your weekly injection in the clinic, with brief, focused appointments designed to fit around your week.

Our pricing is built around three components: your blood tests (pre-treatment screening and ongoing monitoring), your consultations (initial assessment and three-month reviews), and your medication. Each is priced separately, so you only ever pay for what you need. Pre-treatment bloods are £95, your initial consultation is £285 (60 minutes), and 30-minute follow-up reviews are £175 each. Medication is charged based on what’s prescribed. If you would prefer in-clinic injections, this is charged at £135 per month for up to four injections.

Online clinics often offer flat-fee monthly subscriptions, which can look cheaper at first glance. The trade-offs are the depth of assessment (often a short online questionnaire, with little or no blood testing) and the breadth of monitoring. Updated GMC guidance on prescribing weight loss medication asks prescribers to carry out robust identity, physical and psychological checks that an online form alone can’t replicate, which is exactly what an in-person consultation is designed to do. We price each element separately, so you’re paying for what’s clinically appropriate for you, in person, with continuity of care.

Our clinic is based in Hale, in the heart of South Manchester. We’re easy to reach from Altrincham, Bowdon, Hale Barns, Wilmslow, Knutsford, Alderley Edge, Stockport, Cheadle, Sale, and Manchester city centre. There’s parking nearby, and the clinic is a short walk from Hale train station.

See our Getting Here page for full directions and accessibility information.